Cutaneous T-cell lymphoma developing during nivolumab treatment for metastatic melanoma

Dermatol Online J. 2022 Jan 15;28(1). doi: 10.5070/D328157071.
No abstract available

MeSH terms

  • Humans
  • Lymphoma, T-Cell, Cutaneous* / drug therapy
  • Melanoma* / drug therapy
  • Neoplasms, Second Primary*
  • Nivolumab / adverse effects
  • Skin Neoplasms* / drug therapy

Substances

  • Nivolumab